-
公开(公告)号:US5264555A
公开(公告)日:1993-11-23
申请号:US913138
申请日:1992-07-14
申请人: Robert G. L. Shorr , Kwang Nho , Myung-ok P. Cho , Chyi Lee , Barbara Czuba , Hariharan Shankar
发明人: Robert G. L. Shorr , Kwang Nho , Myung-ok P. Cho , Chyi Lee , Barbara Czuba , Hariharan Shankar
IPC分类号: C07K14/805 , C07K3/02 , C07K3/12 , C07K3/22 , C07K15/06
CPC分类号: C07K14/805
摘要: Methods are disclosed for separating hemoglobin from erythrocytes by contacting erythrocytes with a hypotonic buffer solution at a rate sufficient to render the release of hemoglobin from said erythrocytes without significant lysis. The hemoglobin is then separated from the erythrocytes. Methods are also disclosed for purifying hemoglobin solutions of DNA, endotoxins and phospholipids by contacting the hemoglobin solutions with an anion exchange medium.
摘要翻译: 公开了通过使红细胞与低渗缓冲溶液接触的速率,以足以使血红蛋白从所述红细胞中释放而没有显着裂解的速率来分离血红蛋白与红细胞的方法。 然后将血红蛋白与红细胞分离。 还公开了通过使血红蛋白溶液与阴离子交换介质接触来纯化DNA,内毒素和磷脂的血红蛋白溶液的方法。
-
2.
公开(公告)号:US20090285780A1
公开(公告)日:2009-11-19
申请号:US12302238
申请日:2007-05-24
申请人: Chyi Lee
发明人: Chyi Lee
IPC分类号: A61K47/48 , C07C237/12 , C07C237/06 , C07C231/00 , A61K38/21 , A61K38/00
CPC分类号: C07K19/00 , A61K47/60 , A61K2039/6093
摘要: PEG linker compounds and biologically active conjugates thereof having mixed functional group linkages attached to at least one PEG moeity, and a coupling group for attaching a biologically active molecule. The PEG mixed linkages can be the combinations of stable, or labile, or releasable, or stable and labile, or stable and releasable, or releasable and labile covalent linkages. The mixed functional linkages of the PEG linker compounds consist of different organic functional groups, which have non-equivalent half-life in plasma and, hence, they have different release rates in blood. The present invention also provides for attachment of novel PEG linker compounds with mixed functional linkages for Pegylation of biologically active molecules to produce Probiomolecule-PEG constructs. The Probiomolecule-PEG construct is the prodrug of biomolecule-PEG conjugate or biomolecule. The Probiomolecule-PEG conjugate will gradually lose portions (or all) of its PEG polymers in vivo to convert into smaller size biomolecule-PEG conjugate (or biologically active molecule), thereby increasing their biological activity in vivo.
摘要翻译: PEG连接体化合物及其与至少一种PEG摩尔系连接的混合官能团键的生物活性缀合物和用于连接生物活性分子的偶联基团。 PEG混合键可以是稳定的或不稳定的,或可释放的,或稳定的和不稳定的,或稳定的和可释放的,或可释放的和不稳定的共价键的组合。 PEG接头化合物的混合功能键由不同的有机官能团组成,其在血浆中具有非等效的半衰期,因此在血液中具有不同的释放速率。 本发明还提供了新型PEG连接体化合物与生物活性分子的聚乙二醇化混合功能键的连接以产生生物分子-PEG构建体。 生物分子-PEG构建体是生物分子-PEG轭合物或生物分子的前药。 生物分子-PEG缀合物将在体内逐渐失去部分(或全部)其PEG聚合物,以转化为更小尺寸的生物分子-PEG轭合物(或生物活性分子),从而增加其在体内的生物活性。
-
公开(公告)号:US5156840A
公开(公告)日:1992-10-20
申请号:US327881
申请日:1989-03-20
申请人: John W. F. Goers , Hurley D. King , Chyi Lee , Daniel J. Coughlin , Vernon L. Alvarez , John D. Rodwell , Thomas J. McKearn
发明人: John W. F. Goers , Hurley D. King , Chyi Lee , Daniel J. Coughlin , Vernon L. Alvarez , John D. Rodwell , Thomas J. McKearn
IPC分类号: A61K41/00 , A61K47/48 , A61K51/10 , C07K5/083 , G01N33/531 , G01N33/543
CPC分类号: C07K5/0804 , A61K41/0042 , A61K41/0071 , A61K47/48369 , A61K47/48715 , A61K51/10 , A61K51/1093 , G01N33/531 , G01N33/54353 , A61K2121/00
摘要: The invention relates to amine-containing porphyrin derivatives. Theporphyrins can be used as photosensitizers which are useful as therapeutic agents. Also described are methods for preparing conjugates in which a porphyrin derivative is covalently attached to an antibody or antibody fragment. In vivo therapeutic methods utilizing the conjugates are also desired.
摘要翻译: 本发明涉及含胺卟啉衍生物。 卟啉可用作可用作治疗剂的光敏剂。 还描述了制备其中卟啉衍生物与抗体或抗体片段共价连接的缀合物的方法。 还需要使用缀合物的体内治疗方法。
-
公开(公告)号:US20130195799A1
公开(公告)日:2013-08-01
申请号:US13817702
申请日:2011-08-19
申请人: Chyi Lee
发明人: Chyi Lee
IPC分类号: C08G65/333
CPC分类号: A61K47/56 , A61K47/50 , A61K47/60 , C07K1/1077 , C07K17/06 , C08G65/332 , C08G65/33396 , C08L2203/02
摘要: The synergistic biomolecule-polymer conjugates are the long-acting, in vivo controlled continuous-release and hybrid synergy systems of biomolecules that provide increased biological activities and enhanced pharmacological properties for achieving greater therapeutic efficacies.
摘要翻译: 协同生物分子 - 聚合物缀合物是生物分子的长效,体内受控的连续释放和混合协同系统,其提供增加的生物活性和增强的药理学性质以获得更大的治疗功效。
-
公开(公告)号:US4867973A
公开(公告)日:1989-09-19
申请号:US650375
申请日:1984-09-13
申请人: John W. F. Goers , Hurley D. King , Chyi Lee , Daniel J. Coughlin , Vernon L. Alvarez , John D. Rodwell , Thomas J. McKearn
发明人: John W. F. Goers , Hurley D. King , Chyi Lee , Daniel J. Coughlin , Vernon L. Alvarez , John D. Rodwell , Thomas J. McKearn
IPC分类号: A61K41/00 , A61K47/48 , A61K51/10 , C07K5/083 , G01N33/532 , G01N33/534
CPC分类号: G01N33/532 , A61K41/0042 , A61K41/0071 , A61K47/48369 , A61K51/10 , A61K51/1093 , C07K5/0804 , G01N33/534 , A61K2121/00 , Y10S530/828 , Y10S530/864 , Y10S530/866
摘要: This invention relates to antibody-therapeutic agent conjugates having a therapeutic agent covalently attached to an antibody or antibody fragment. Also described are methods for intermediates in the preparation of antibody conjugates. Therapeutic in vivo methods utilizing such antibody-therapeutic agent conjugates are described.
摘要翻译: 本发明涉及具有共价连接于抗体或抗体片段的治疗剂的抗体治疗剂缀合物。 还描述了制备抗体缀合物的中间体的方法。 描述了利用这种抗体 - 治疗剂缀合物的治疗体内方法。
-
公开(公告)号:US4741900A
公开(公告)日:1988-05-03
申请号:US646328
申请日:1984-08-31
申请人: Vernon L. Alvarez , John D. Rodwell , Chyi Lee , John W. F. Goers , Richard C. Siegel , Thomas J. McKearn
发明人: Vernon L. Alvarez , John D. Rodwell , Chyi Lee , John W. F. Goers , Richard C. Siegel , Thomas J. McKearn
IPC分类号: A61K39/395 , A61K41/00 , A61K47/48 , A61K49/08 , A61K51/10 , G01N33/531 , G01N33/532 , G01N33/534 , G01N33/543 , G01N33/577 , A61K43/00 , A61K49/00 , C07K13/00 , C12Q1/00
CPC分类号: A61K49/16 , A61K39/395 , A61K49/085 , A61K51/1093 , G01N33/531 , G01N33/532 , G01N33/534 , G01N33/54353 , G01N33/577 , A61K2121/00 , A61K2123/00 , Y10S435/972
摘要: This invention relates to antibody-metal ion complexes having a metal ion coordinately bound to a compatible chelator covalently bound to an antibody or antibody fragment. Also described are methods for intermediates in the preparation of antibody-metal ion complexes. Therapeutic and in vitro and in vivo diagnostic methods utilizing such antibody-metal ion complexes are described.
摘要翻译: 本发明涉及具有与共价结合抗体或抗体片段的相容性螯合剂配位结合的金属离子的抗体 - 金属离子络合物。 还描述了制备抗体 - 金属离子络合物的中间体的方法。 描述了利用这种抗体 - 金属离子络合物的治疗和体外和体内诊断方法。
-
-
-
-
-